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Leptospirosis remains the most widespread zoonotic disease in the world, commonly found in tropical or temperate
climates. While previous studies have offered insight into intra-national and intra-regional transmission, few have analyzed
transmission across international borders. Our review aimed at examining the impact of human travel and migration on
the re-emergence of Leptospirosis. Results suggest that alongside regional environmental and occupational exposure,
international travel now constitute a major independent risk factor for disease acquisition. Contribution of travel associated
leptospirosis to total caseload is as high as 41.7% in some countries. In countries where longitudinal data is available,
a clear increase of proportion of travel-associated leptospirosis over the time is noted. Reporting patterns is clearly
showing a gross underestimation of this disease due to lack of diagnostic facilities. The rise in global travel and
eco-tourism has led to dramatic changes in the epidemiology of Leptospirosis. We explore the obstacles to
prevention, screening and diagnosis of Leptopirosis in health systems of endemic countries and of the returning
migrant or traveler. We highlight the need for developing guidelines and preventive strategies of Leptospirosis
related to travel and migration, including enhancing awareness of the disease among health professionals in
high-income countries.
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Leptospirosis has traditionally been described in the
medical literature as a treatable zoonotic disease endemic
to low-income countries in temperate and tropical regions
[1]. As a clinical entity it is strongly associated with
regional occupational and environmental exposures [2].
WHO Leptospirosis Burden Epidemiology Reference
Group (LERG) estimates [3], 873,000 annual cases and
48,000 deaths due to leptospirosis [4]. The countries with
the highest reported incidence are located in the Asia-
Pacific region (Seychelles, India, Sri Lanka and Thailand)
with incidence rates over 10 per 1000,000 people s well as
in Latin America and the Caribbean (Trinidad and
Tobago, Barbados, Jamaica, El Salvador, Uruguay, Cuba,
Nicaragua and Costa Rica) [5].
In recent years however, recreational exposure to
water has emerged as a strong risk-factor for disease* Correspondence: sunethagampodi@yahoo.com
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unless otherwise stated.transmission [6]. Over the past twenty years, leptospir-
osis cases diagnosed among international travelers have
become increasingly common [7] and the disease is now
emerging as a major public health concern worldwide
[5]. Both neglected and under-reported, there is scant
epidemiological data on leptospirosis therefore masking
the true scope of disease prevalence and making reliable
morbidity and mortality statistics difficult to ascertain
[3]. Chronic underreporting of leptospirosis is due in
large part to clinical misdiagnosis [8]. Patients present
with clinical signs difficult to distinguish from other en-
demic illnesses including dengue fever, malaria, HIV,
rickettsial disease and yellow fever. Further, regional and
district level health centers often lack appropriate diag-
nostic laboratories to perform the serological testing re-
quired to establish a diagnosis [9].
To date, studies investigating leptospirosis have described
high disease prevalence among economically marginalized
populations in endemic regions. Urban slums [10-15] lack-
ing access to adequate sewage disposal and water treatment
infrastructure as well as rural farming communities work-
ing in rice [16-20] or sugar cane fields [21-23] have beenl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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populations are particularly vulnerable to seasonal mon-
soons and flooding which can heighten the risk of trans-
mission and lead to outbreaks and possible epidemics.
Additionally, high-risk occupational groups for the disease
include fishermen [24], sewer workers [25], dairy industry
workers [26], veterinarians [27], miners [28] and military
personnel [29-32]. In countries where disease is regionally
endemic, internal migration patterns and exposures are
crucial risk factors for the spread of the disease.
The rise in global travel and eco-tourism [33] has led to
dramatic changes in the epidemiology of leptospirosis.
Despite decreasing prevalence of leptospirosis in endemic
regions, previously non-endemic countries are now
reporting increasing numbers of cases due to recre-
ational exposure [34]. International travelers engaged
in adventure sports are directly exposed to numerous
infectious agents in the environment and now comprise a
growing proportion of cases worldwide. Similarly, in recent
years outdoor athletic events have been linked with several
outbreaks among foreign travelers.
To date, the global impact of international travel and
migration as a major determinant of leptospirosis trans-
mission has yet to be thoroughly analyzed in the medical
literature. In this paper we aim to evaluate the impact




We conducted a comprehensive review of existing lepto-
spirosis literature via online databases. Our principle aim
was to identify all studies published in peer-reviewed
journals and indexed in PubMed that explored the as-
sociation between human migration and leptospirosis
published through March 2013. Although non-English
studies were excluded, we extracted data from studies
that had English abstracts. To identify relevant articles
not found in PubMed, we supplemented the search
strategy by first searching the indices of several journals
manually: Travel Medicine and Infectious Disease, Journal
of Travel Medicine, International Medical Travel Journal,
International Journal of Travel Medicine and Global
Health, and second by reviewing reference lists of primary
studies.
Inclusion criteria and definitions
Studies that reported confirmed and probable cases of
leptospirosis were deemed eligible for inclusion. Reviewers
screened citations by reviewing titles and abstracts to iden-
tify potentially relevant studies. Disagreements between the
reviewers were resolved by consensus. The database was
then screened a second time using more focused inclusion
criteria to isolate only primary articles. Subsequently the fulltext of each citation was obtained and reviewed. In cases
where full articles could not be obtained, the article abstract
was used. We adopted the case-definition of leptospirosis
based on the guidelines from the LERG [35] to include
studies in the review. No restrictions were made with re-
gard to the outcome variables as this was a review of obser-
vational studies.
Data extraction
A data collection form was prepared and pilot tested prior
to data extraction activities begun. In order to minimize
biases in data extraction, the methods of selected studies
were reviewed in detail by two independent reviewers
under the supervision of the principle investigator. Sub-
group analyses were done to minimize heterogeneity across
studies. Data were pooled only when studies were reason-
ably consistent in their methods. Variables were examined
in detail, including: number of cases, country of residence,
exposure country/region, proportion of travel related cases,
type and nature of study (population based vs. hospital
based cohort), type of exposure, time period and year.
Results
Of the 10,289 articles we identified on leptospirosis, only
141 met the key-word criteria related to travel/migration.
We identified a total of 149 potentially relevant citations
from both the PubMed and cumulative literature search
once duplicate references were removed. These were fur-
ther reduced to 60 after undertaking a title and abstract re-
view. Following an in-depth review of the full-texts of these
papers 48 were included for final analysis (Figure 1).
Of the 54 publications, 33 reported individual travel
reported leptospirosis cases or case reports, nine re-
ported cases by country and/or regional caseload and six
reported cases in the context of travel related fever.
After the full text review 12 articles were excluded from
final qualitative analysis. We excluded a case acquired
due to an imported animal, five reports without primary
data and six reviews from the final qualitative data ana-
lysis. All studies we encountered clearly identified the
geographical region where disease was acquired.
Data extraction was completed for 3 distinct subgroups:
1. Papers citing travel as a significant contributory
factor to overall country level leptospirosis case
loads (9 studies)
2. Those that highlighted the contribution of
leptospirosis to larger trends in travel associated
fever (5 studies); and
3. Case reports and case series illustrating travel-
associated leptospirosis (33 studies)
The nine studies reporting cases of leptospirosis
among travellers or migrants as a proportion of the
Figure 1 Selection of studies for review.
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Netherlands [36,37], Israel [38], Germany [39,40],
Austria [39], Japan [41,42], Thailand [43] and the USA
[44] (Table 1), all of which are high-income nations
with the exception of Thailand. In the USA, country
level data was not available, but complete data set for
Hawaii was available only up through 2008.
Among reports of systematically collected country
level data, Israel reported the highest incidence of travel
associated leptospirosis (41.7%). In Germany, before
2003 this contribution was only 15.7%. However, a later
study showed that the travel related cases increased up
to 40.7% in 2008. Netherland has the largest reported
database describing travel associated leptospirosis which
included 318 cases out of 2553 cases related to inter-
national travel. In Germany and Netherlands, intra-country
travel comprised over 40% of the disease burden. One study
conducted in Germany using aggregate data from 1962–
2002 found that 13 out of 39 travel related leptospirosis
cases were acquired from European countries where lepto-
spirosis is rare, with the majority of these cases occurring
between 1960 and 1980. The study results suggest that in
the last two decades, this trend has shifted, with Latin
America and Caribbean Islands serving as the main geo-
graphical location for disease transmission and infection
among German nationals. Data from Japan reports that
around 7% are none residents thus travel related. Data from
Hawaii shows that 5.7% of leptospirosis cases reported in
Hawaii were from mainland USA and 23% from smallerislands. Other than Hawaii islands where Leptospirosis is
endemic and disease transmission was within the state, the
major contribution to travel related leptospirosis was from
southeast Asia/Asia.
Contribution of leptospirosis to travel associated fever
was reported among more than 7000 febrile cases in six
studies (Table 2). All studies were from developed coun-
tries. Leptospirosis was responsible for 0.21% to 2.65% of
all travel associated fever cases. Among Western trav-
elers, which included travelers from North America,
Europe, Israel, Japan, Australia and New Zealand,
leptospirosis contributed to 2.65% of all travel related
febrile illnesses [45]. Individual reports from Sweden
[46], Australia [47] and Finland [48] and combined re-
ports by Flores-Figueroa et al. [49] and Field et al. [50]
showed less than 1% contribution. South East Asia was
reported as the main exposure area.
Of the 27 case reports and 6 case series, 3 reported on
leptospirosis due local travel within the country. Two of
these studies examined transmission from the continen-
tal US to Hawaii [51,52] and from the Jordan River
Valley in Israel to the northern part of the country [32].
All other case reports were focused on infection second-
ary to travel outside of the patients’ country of residence
(Table 3) which included 11 countries; Germany (7)
[53-59], Netherlands (5) [60-64], France (5) [65-69]
Australia (3) [70-72], USA (4) [73-77], Israel (1), Canada
(1) [78], Norway (1) [79], Italy (1) [80], Japan (1) [81],
and Sweden (1) [82]. Leading exposure countries were
Table 1 Country level data and proportion of travel related leptospirosis












Netherlands 1925 - 2008 2553 318(12.5%) Europe – 132 Recreational- 257, Culture/MAT
Asia – 134
South America – 25 Job-related 21,
Central and North
America – 13 Accidental 22,
Sub-Saharan Africa – 7
Middle East – 2
Australia – 1










1998-2008 59 24(40.7%) Caribbean - 10, Recreational ELISA, MAT, PCR
Asia - 9, Eastern Europe - 3,
Central America - 1,
South America - 1
Taniguchi et al., [42] Japan 1999-2008 95 7(7.4%) Not mentioned Not mentioned Not mentioned













Thailand 1994 - 2000 59 10(16.9%) Northeastern part of
Thailand
Katz et al., [44] USA 1974 - 1998 752 43(5.7%) 43 - outside the state
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Table 2 Leptospirosis cases detected out of travelers presenting with fever
Reference Country Period of study Total cases Total fever cases Country of exposure Type of travel




1996 – 2011 88(2.65%) 3326 Caribbean - 7,
Central America - 15,
North Africa - 3, Oceania - 2,
South America - 4,
South Central Asia - 3,
Southeast Asia - 49
(Thailand - 19, Laos - 11),















Siikamaki et al., [48] Finland (Helsinki) 2005 – 2009 1(0.21%) Asia Unknown






Askling et al., [46] Sweden 2005-2008 7(0.50%) 1432
Tropical countries - Africa,
Asia, America
Unknown
Goldsmid et al., [47] Australia (Tasmania) 1 NR India Studies (river)
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Malaysia and Philippines which accounted for more
than 1/3rd of cases. All case reports and case series were
from high income countries.
Discussion
The results from this review suggest a dynamic shift in
the epidemiology of leptospirosis transmission due to
increased human travel and migration on a global
scale. While previous studies have offered insight
into intra-national and intra-regional transmission, few
have analyzed transmission across international bor-
ders. The results presented here suggest that secondary
transmission of leptospirosis via human travel and mi-
gration across national borders is re-shaping the land-
scape of disease incidence and prevalence worldwide.
Alongside regional environmental and occupational
exposure, international travel now constitutes a major
independent risk factor for disease acquisition.
Despite increases in travel-associated disease, the
overall contribution of diagnosed leptospirosis to cases
of febrile illness in returning travelers is still quite low
(2.4%) [45]. This discrepancy is likely due to the lack of
clinical suspicion among home-country clinicians as
leptospirosis is rarely included in the differential diag-
nosis outside of endemic regions. Additional obstacles
to diagnosis include the lack of home-country diagnostic
facilities and general diagnostic inaccuracy due to serovar
diversity between geographic regions. Countries having
the highest number of cases detected in travelers return-
ing from endemic regions (United States, Netherlands,
Japan, France, Germany and Australia) are also equipped
with highly developed reference laboratories, diagnosticcapacity and research facilities. Such capacities may be
limited in developing countries where tourist travel to en-
demic countries is equally common, ultimately leading to
poor case detection and reporting bias.
In an era of globalization with increased global travel
and migration, diseases that were thought to be
isolated to tropical regions or affecting marginalized
communities can no longer be considered as ‘tightly con-
tained’ static entities [5]. It is imperative to view new inter-
national trends in transmission as a direct outgrowth of
globalization. Such diseases are not emerging threats,
but rather have been threats all along. Confined to
mostly impoverished fishing and rice farming commu-
nities, Leptospirosis has for many decades gone largely
undetected and neglected. The disease has also been a
leading cause of morbidity and mortality in such com-
munities for generations. Although Leptospirosis re-
mains the most widespread zoonotic disease in the
world, the greatest burden of the disease still remains
with such marginalized communities. They face daily
occupational exposure risks in order to earn their live-
lihoods. The new trends in global transmission stands
as an important reminder that it is essential to design
and implement a rigorous disease detection, preven-
tion and treatment plan starting first at the community
level.
Due to the complexity of the disease transmission,
primary prevention of leptospirosis is difficult. In low
and middle income tropical countries, the ecological
system provides a conducive environment for lepto-
spirosis transmission. Identification of local ‘hot spots’
of leptospirosis may help facilitate preventive activities.
Public health authorities in endemic areas should
Table 3 Case reports and case series on travel related leptospirosis
Reference Country Country of exposure Region/City Disease confirmation
Walter et al., [54], Germany Canada
Grobusch et al., [53] Germany Dominican Republic Playa Dorada, Santiago/Los Ciruelitos,
Santa Domingo, Juan Dolio, Mao
ELISA
Teichmann et al., [59] Germany Philippines MAT
Green and Busuttil, [58] Germany Sardinia
Bernasconi et al., [57] Germany Switzerland Southern
Steffens et al., [56] Germany Thailand Serology, PCR
Seilmaier and Guggemos [55] Germany Thailand and Laos Serology
Gelman et al., [73] USA Ecuador, Costa Rica Culture, Dark field microscopy
Duplessis et al., [51] USA Hawaii Maunuwili falls
Pashkow et al., [75] USA Honduras
Haake et al., [76] USA Malaysia Sabah Dip-S-Ticks, PanBio ELISA, Culture
Mortimer [74] USA Malaysia Sarawak
Coursin et al., [52] USA USA Hawaii MAT
Monsuez et al., [67] France Africa Cote d’Ivoire (Ivory Coast) ELISA
Perret et al., [68] France Gabon IgM
Jaureguiberry et al., [66] France Ivory Coast - 1, China - 1 ELISA, MAT
Simon et al., [69] France Mauritius Island ELISA, MAT, PCR
Arzouni et al., [65] France Portugal and Spain Dark field microscopy, PCR,
Western blot, Culture
Maldonado et al., [64] Netherlands China MAT
Arcilla et al., [60] Netherlands Dominican Republic Altos de Chavón MAT, ELISA, PCR
Wagenaar et al., [63] Netherlands Malaysia Langkawi island ELISA, MAT
Helmerhorst et al., [61] Netherlands Thailand Bangkok and the North of Thailand MAT
Kager et al., [62] Netherlands Thailand Serology Culture
Heron et al., [70] Australia Africa, Ghana Ghana
Gill et al., [71] Australia Fiji ELISA (IgM)
Korman et al., [72] Australia Indonesia Kalimantan MAT, Culture, Dark field microscopy
Hadad et al., [32] Israel Israel Jordan river (Nothern Israel) MAT
Paz et al., [77] Israel Thailand, Cambodia Kochang island, Thailand MAT
Leung et al., [78] Canada Malaysia Northeastern Malaysia ELISA, MAT
Lagi et al., [80] Australia Italy Venice PCR, MAT
Sakamoto et al., [81] Japan Indonesia Bali island Dark field microscopy, MAT
Myrstad et al., [79] Norway France Southern France IgM, IgG
Guron et al., [82] Sweden Thailand Serology
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monitor epidemiological trends with the goal of actively
identifying geographical areas which would benefit from in-
creased service provision and education. If these hot spots
correspond with mass gatherings or tourist attractions, then
application of targeted primary and secondary preventive
measures may become more feasible. As an example, re-
cent reports of internal travel associated leptospirosis
occured in Sri Lanka, in a place where white color workers
were engaged in water sport [83]. Interventions were
needed to target those involved in organizing recreationaltravel packages for white-water rafting in such settings.
Strategies may also include participant education and
chemoprophylaxis to prevent leptospirosis in those register-
ing for such activities. Recent increase in leptospirosis
among people engaged in water sports also pose the ques-
tion of whether chemoprophylaxis should be taken as a
routine practice. Since the evidence to support the use of
chemoprophylaxis is still poor, more studies are needed to
inform decision making [84].
The results of this review highlight the urgent need for
developing travel guidelines and preventive strategies of
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among health professionals practicing in high-income
countries where the disease seems exotic is essential for
proper diagnosis and treatment. Further, stake holders
such as tour companies, adventure sport organizers
should also receive adequate knowledge on the increas-
ing risk of leptospirosis.
Further research is needed to investigate the impact of
occupational migration and forced displacement on
leptospirosis prevalence and disease distribution. Given
that migrant workers and refugees are often the most
marginalized and underserved communities, detection,
treatment and prevention of leptospirosis among this
high-risk cohort has been largely ignored to date. Lastly
additional studies are needed to assess the efficacy of
long-term chemoprophylaxis with doxycycline and to
identify other alternative less toxic agents for long-term
use in high-risk groups.
We undertook our literature review using PubMed as
the main electronic database with hand-searches of se-
lected bibliographies to identify additional relevant liter-
atures. This may not have captured an exhaustive list of
literature. We did not analyze the disease transmission
risk associated with the total length of time traveling, ex-
posure history, route of transmission, visits to multiple
regions in succession, occupation and clinical presenta-
tion stand as possible confounding variables which
should be done in future studies.
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